Got $2,000? 4 Top Stocks to Buy This Month

Canadians with only $2,000 in capital can create a diversified portfolio that could deliver substantial gains. The top but affordable buys are Alcanna stock, BELLUS Health stock, Cineplex stock, and Diversified Royalty stock.

| More on:
Dice engraved with the words buy and sell

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

In alphabetical order, what do Alcanna (TSX: CLIQ), BELLUS Health (TSX:BLU)(NASDAQ:BLU), Cineplex (TSX:CGX), and Diversified Royalty (TSX:DIV) have in common? Well, these four stocks are the top buys on the TSX in May 2021. If you have $2,000 to invest today, you can purchase $500 worth of each stock and expect substantial gains.

Specialty retail

Alcanna is a premier retailer of alcohol and highly regulated controlled substances (wines, beers, spirits, and cannabis) in North America. The $252.7 million company from Edmonton is a dynamic organization with 250 liquor and cannabis retail outlets.

As of May 21, 2021, the share price is $6.98, and thus far, current investors are enjoying a 17.91% gain. Market analysts recommend a strong buy rating and foresee further gain of 97% to $13.75 in the next 12 months. Alcanna’s trailing one-year price return in 220.18%.

In Q1 2021 (quarter ended March 31, 2021), total sales grew by 2.8% to $142.2 million versus Q1 2020. From a net loss of $9.2 million, Alcanna reported $47.6 million in net earnings. During the same quarter, the company partnered with YSS to form Nova Cannabis, a new discount-focused cannabis retailer.

Growth driver in the making

While BELLUS Health trades at only $4.66 per share, analysts forecast a 157.5% price appreciation to $12. Your $500 could potentially grow to $787.50 in one year. The healthcare stock is also among the better performers in 2021 with its 21.67% year-to-date gain.

The $365 million clinical-stage biopharmaceutical firm develop novel therapeutics to treat chronic cough and other hypersensitization-related disorders. Its lead product candidate is BLU-5397, a highly selective P2X3 antagonist. Once it passes clinical trials and receives regulatory approval, BLU-5397 may be the viable treatment option for patients suffering from chronic cough or chronic pruritus associated with atopic dermatitis.

A faster-than-expected recovery

The Cineplex stock is recovering from the pandemic faster than expected. Its year-to-date gain is 51.02%, and according to analysts, the current share price of $14 could hit $17 or a 21.4% upside in the near term. COVID-19’s impact on the business is brutal because the most prominent theatre operator in Canada lost its propensity to generate revenues as it had in the past.

Unlike in the U.S., cinemas in Canada have yet to enjoy a return to business. Traditional cinemas are also losing a lot of ground from streaming services like Amazon and Netflix. Despite the challenges and threats to the movie exhibition industry, investors are happy with Cineplex’s remarkable comeback.

Pure dividend play

Diversified Royalty is a cheap dividend play. At $2.51 per share, would-be investors can partake of the juicy 7.97% dividend yield. Don’t expect much capital gain, although the royalty stock is up 9.03% year to date.

The $305 million multi-royalty corporation from Vancouver acquires royalties from multi-location businesses and franchisors in North America. Currently, Diversified Royalty owns the trademarks to AIR MILES, Mr. Lube, Mr. Mikes, Nurse Next Door, Sutton, and Oxford Learning Centres.

In Q1 2021 (three months ended March 31, 2021), the royalty firm’s top line increased 4.8% to $7.6 million compared to Q1 2020. Notably, net income for the quarter was $4.1 million versus the net loss of $11.7 million in the same period last year.

Diversified portfolio

Canadians with just $2,000 to invest can build a diversified portfolio. All four stocks display respectable performances in 2021, notwithstanding the continuing pandemic.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Christopher Liew has no position in any of the stocks mentioned. David Gardner owns shares of Amazon and Netflix. Tom Gardner owns shares of Netflix. The Motley Fool owns shares of and recommends Amazon and Netflix. The Motley Fool recommends CINEPLEX INC and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

2 Oversold TSX Dividend Stocks to Buy Now and Own for 25 Years

These top TSX dividend stocks look oversold and now offer attractive yields for TFSA and RRSP investors.

Read more »

Profit dial turned up to maximum
Dividend Stocks

RRSP Investors: 2 Undervalued TSX Stocks to Buy Now for Total Returns

Top TSX dividend stocks are now on sale for RRSP investors seeking attractive total returns.

Read more »

TFSA and coins
Dividend Stocks

2 Beaten-Down Stocks to Buy for Your TFSA

Two beaten-down, but high-yield TSX stocks are profitable options for TFSA investors.

Read more »

Hand writing Time for Action concept with red marker on transparent wipe board.
Dividend Stocks

Inflation Soars to 7.7%: 1 Dividend Stock to Buy Now

Enbridge (TSX:ENB)(NYSE:ENB) stock looks like a magnificent dividend stock to help Canadians deal with inflation at 7.7%.

Read more »

Dividend Stocks

RRSP Investors: 2 Oversold Dividend Stocks to Buy Now for Total Returns

These great Canadian dividend stocks look cheap today for an RRSP focused on total returns.

Read more »

Volatile market, stock volatility
Dividend Stocks

2 Dividend Stocks to Own When the Market Is in Turmoil

Two TSX stocks can sustain dividend payments, even if the present market turmoil extends longer than expected.

Read more »

Various Canadian dollars in gray pants pocket
Dividend Stocks

3 Passive-Income Stocks to Help You Through This Market Correction

These three passive-income stocks offer stellar dividends around 6% to help get you to the other side of this market…

Read more »

Coworkers standing near a wall
Bank Stocks

Policy Rate: 2 More Hikes After July 2022 to Reach Neutral Level

The Bank of Canada might need three more rate hikes beginning in July 2022 to reach neutral levels.

Read more »